Pharmaceutical Companies Worldwide

Livmed's is a software platform that provides home medicine delivery services for fellow citizens and healthcare players.

Camurus is a Swedish science-led biopharmaceutical company committed to developing and commercializing innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal® drug delivery technologies and its extensive R&D expertise. Camurus’ clinical pipeline includes products for the treatment of opioid dependence and chronic pain, rare diseases, oncology and supportive care, which are developed in-house and in collaboration with international pharmaceutical companies. The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX.

Our vision is to deliver “AI Brains” that closely resemble human brains that perceive, understand and continuously learn. We are achieving our vision through deploying AI capabilities closer to human level intelligence through the use of unlabeled data, unsupervised few-shot learning, knowledge consolidation and sharing. We deliver brain-inspired AI solutions that enable our select customers and partners to maximally exploit the functionality and performance of Brain-Sense™ technology to reduce costs and enhance our customers’ end-product and service capabilities - continuous AI learning of new use cases from unlabelled data using only a few reference examples, and transfers this learnt knowledge across multiple devices. This novel technology enables a set of new possibilities that minimizes the need for big data and allows for faster learning and more intelligent AI that adapts to changing real life conditions.

Minoryx is a registration stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company’s lead program, leriglitazone (MIN-102), a novel, brain penetrant and selective PPAR gamma agonist, is being developed in X-linked Adrenoleukodystrophy (X-ALD) and other orphan CNS diseases. The company is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chiesi Ventures, S.R.I.W, Idinvest Partners / Eurazeo, SFPI-FPIM, HealthEquity, Sambrinvest and Herrecha, and has support from a network of other organizations. Minoryx was founded in 2011, is headquartered in Spain with Belgian facilities and has so far raised more than €120 million

Nuclera is making biology accessible by providing researchers a desktop bioprinter capable to produce genes and proteins in one day. Biological research and drug discovery projects begin with and rely on proteins. However, using traditional methods to obtain proteins of interest can take up to 6 months and often include many trials and failures. What if there was an easier way? At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein Discovery™ system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges, allowing rapid progress on protein projects through a benchtop, automated, high-throughput protein access system. Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.

Our mission is to help life sciences companies accelerate drug development for improved patient outcomes, and we do this by championing the power of data. Our main product DISQOVER is an optimized search or knowledge platform which draws on semantic technology and an ontology-based knowledge graph to find links between data across databases (internal data, public data and third party data) faster and more efficiently. The platform has been developed for the pharmaceutical and biotech industries. There are thousands of health research databases, clinical trials, literature reviews, patient studies, etc. available. Before setting up a new study, scientists first need to check what kind of research has already been done – both internally and externally – on, for instance, growth hormone applications for a particular disease. In many companies, even internal information resides in hundreds of different databases, each with their own interface and search logic. As a consequence, just finding this kind of background information is a very time-consuming process. This is where DISQOVER comes in. One of the assets is that we use semantic technology to find logical but often hidden connections between internal and external data, allowing you to easily combine information from a multitude of different sources. As such, pharma and biotech companies can save valuable time and money that they can now invest in developing new medicines or treatments. Customers include: AstraZeneca, AmGen, Medidata, Prinses Máxima Institute, Aelin Therapeutics and more. DISQOVER is used amongst others by scientific researchers, bioinformaticians, and data scientists. Try DISQOVER: our community edition is always up-to-date and accessible via www.ontoforce.com (choose “try now” top right corner)

We are a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists. Our first commercial product, XHANCE® (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing our proprietary Exhalation Delivery System™ (EDS®) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). In September 2017, the U.S. Food and Drug Administration (FDA) approved XHANCE for the treatment of nasal polyps in patients 18 years of age or older. XHANCE was made widely available through commercial channels in April 2018. In March and June 2022, we announced positive top line results from our two Phase 3b clinical trials (ReOpen1 and ReOpen2) of XHANCE for a follow-on indication for the treatment of chronic sinusitis. In February 2023, we submitted a prior approval efficacy supplement (sNDA) to support the approval of a new indication for XHANCE for the treatment of chronic rhinosinusitis. If the sNDA is approved, XHANCE has the potential to be the first drug therapy approved by the FDA for the treatment of chronic sinusitis. As of February 20, 2023, we had a total of 141 full-time employees all of whom are in the United States, and no part-time employees. Culture is a critical element in the management of our organization. Our colleagues are focused on driving our business with the Optinose values as the foundation for all our efforts. Our goal is that each colleague feels a deep connection to what they do, loves coming to work and is aligned to our One Mission – to improve lives. Our values of Authenticity, Fearless Conversations, Friendship, Openness, Perseverance and Possibility Thinking guide our actions and decisions.

OSE Immunotherapeutics is an integrated biotech company focused on developing first-in-class assets targeting cancer and inflammatory diseases. A current well-balanced first-in-class clinical pipeline including: • Tedopi® (T-cell specific immunotherapy): Company’s most advanced product; positive results for Ph 3 in NSCLC in secondary resistance after CKI failure. Other sponsored combo Ph 2 trials in solid tumors ongoing. • OSE-279 (anti-PD1) advanced preclinical stage • OSE-127 (humanized mAb antagonist of IL-7R); ongoing Ph 2 in Ulcerative Colitis; ongoing preclinical research in leukemia • VEL-101/FR104 (anti-CD28 mAb) developed in partnership with Veloxis in transplantation; ongoing Ph 1/2 in renal transplant (sponsor Nantes University Hospital); Ph 1 ongoing in the US (sponsor Veloxis). • BI 765063 (anti-SIRPα mAb on CD47/SIRPα pathway) developed in partnership with Boehringer Ingelheim in advanced solid tumors; positive Ph 1 dose escalation results in mono and in combo, in particular with anti-PD-1 antibody ezabenlimab; BI sponsored international Ph 1b clinical trial ongoing in combo with ezabenlimab alone or with other drugs in recurrent/metastatic HNSCC and HCC. OSE Immunotherapeutics expects to generate further significant value from its two proprietary drug discovery platforms, which are central to its ambitious goal to deliver next-generation first-in-class immunotherapeutics: • BiCKI® platform focused on immuno-oncology (IO) is a bispecific fusion protein platform built on the key backbone component of anti-PD1 combined with a new immunotherapy target to increase anti-tumor efficacy. Most advanced BiCKI® candidate is targeting anti-PD1xIL-7. • Myeloid platform focused on optimizing the therapeutic potential of myeloid cells in IO & immuno-inflammation (I&I). OSE-230 (ChemR23 agonist mAb), most advanced candidate generated by the platform, with the potential to resolve chronic inflammation.

UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With more than 8700 employees in approximately 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2022 Key Financials: €5.5 billion global revenue Specialties: Neurology, Immunology

We are experts in developing novel sub-unit vaccines Our initial focus is on animal health. We aim to capitalize on the first approval of a CrisBio® - based vaccine dossier (expected in 2020) to expand into human health and thereby fully exploit the platform’s potential. CrisBio® also has applications in the Diagnostics sector, where it is already being exploited by a commercial partner. Our current portfolio comprises 6 vaccines across livestock species. Proof of concepts have been generated in > 20 additional vaccine antigens Value through collaborations Our go to market strategy is inherently linked to collaborations. We offer: • Development of tailor-made baculovirus vectors optimized for industrial production. • Proof-of-concept studies to validate the production of recombinant proteins in CrisBio®. • Supply of recombinant proteins produced in CrisBio® through license agreements. • Development of proprietary portfolios. Algenex is led by an internationally experienced management team, that is supported by a well-balanced Strategic Advisory Board that combines industry and investment experience.

Maintaining musculoskeletal health is the keystone of overall health as we get older. As we age our physical condition gradually deteriorates, leading to loss of strength, fitness and mobility. In most cases, this isn’t due to a simple decision to stop exercising. It is due to the breakdown of musculoskeletal function caused by disease. Musculoskeletal diseases such as osteoarthritis, tendinopathy and lower back pain are the primary causes of disability and early retirement in people over the age of 65. Currently, there are no approved disease-modifying drugs for these diseases, meaning that physical decline in old age is inevitable. At Causeway, we believe that physical decline in old age is not inevitable and in indeed may be reversible. To address this, we are developing a range of therapies that treat common MSK diseases that will allow us to remain fit and active into our nineties and beyond. Staying active as we get older also reduces the risk of developing osteoporosis, dementia, diabetes, obesity, cancer and cardiovascular disease. Finding a way to remain fit and active as we age isn’t just a personal imperative but also a global one. By 2050, one in four of us will be over 65 years old, the number of people age over 80 is projected to triple and retirement age to rise to 75-80 years old. As individuals and as a society, we need to find solutions to the problems of ageing. Our goal is to develop therapies that treat the most common MSK diseases, such as osteoarthritis, tendinopathy and lower back pain, re-defining what old age looks and feels like.

Biovian is a One-Stop-Shop GMP CDMO in biopharmaceuticals, covering services from early development to finished vial. Biovian's 4,600 m2 facilities are EMA certified and FDA inspected for GMP production of investigational and commercial products. Biovian GMP services: - Virus production for gene therapy and vaccines - Microbial production of recombinant proteins and plasmid DNA - Process development - Formulation - Fill & Finish - Analytical quality control - Cell and virus bank preparation

FinVector is a fast-growing and internationally renowned biopharmaceutical company that develops and manufactures viral-based gene therapy products. As a pioneer in its operational field, FinVector has extensive experience of nearly 30 years in cGMP manufacturing. The company’s operations are centred in Kuopio, Finland. As a truly international workplace, FinVector employs hundreds of professionals that represent numerous nationalities. FinVector works on cutting-edge biopharmaceuticals and has invested in building state-of-the-art development and GMP facilities for Viral Vector and Cell Therapy platforms including vaccines. FinVector is owned by Ferring Ventures, a subsidiary of Ferring Foundation B.V. Learn more: www.finvector.com Instagram: @we_are_finvector - https://www.instagram.com/we_are_finvector/ LinkedIn: FinVector Oy - https://www.linkedin.com/company/finvector/

Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars.

Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the-counter brands (OTC) and biosimilar products for patients around the world. We are passionate about making people’s lives better by making high quality medicines more accessible around the world. The company has commercial operations in 35 countries with 2,800 employees and operates four manufacturing and development hubs in the U.S., Romania, Korea and Taiwan. North America is Alvogen’s single largest market and other key markets include: South Korea, Russia, Taiwan, Romania, Hungary, Ukraine, Japan and China.

PRICH Biotech stands, since its very beginning, as the industry leader in the medical cannabis industry of Puerto Rico. Operating in first tier pharmaceutical grade facilities, PRICH Biotech with its talented staff, genetics of our mother bank, and proprietary techniques has helped create the highest premium quality products and standards. This combined with our competitive prices, product depth and availability position PRICH Biotech as the favorite brand for Puerto Rico’s patients.

Saama develops life science solutions that create efficiency and accelerate the delivery of therapies to patients. With innovative AI/ML technologies, Saama drives breakthrough intelligence into clinical and commercial operations. Saama's Life Science Analytics Cloud (LSAC) powered the clinical trial that led to the world's first COVID-19 vaccine. Headquartered in Campbell, CA, with employees around the globe, Saama is committed to helping customers save and improve lives. Discover more at www.saama.com

Acino is a Swiss pharmaceutical company headquartered in Zurich, with a clear focus on high-growth markets. We deliver quality pharmaceuticals to promote affordable healthcare and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing. For more information: www.acino.swiss *** By engaging with Acino on YouTube (or any other Acino social media channel), you are agreeing to our Social Media Community Guidelines. If you do not agree to them, do not engage with Acino on social media. Please read our detailed community guidelines carefully here: https://acino.swiss/acino_social_media_community_guidelines_may2022 ***

Medable's mission is to get effective therapies to patients faster. We provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Our solutions enable more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine. Our vision is to accelerate the path to human discovery and medical cures. We are passionate about driving innovation and empowering consumers. We are proactive, collaborative, self-motivated learners, committed, bold and tenacious. We are dedicated to making this world a healthier place.

Tata 1mg is India’s leading consumer health platform. It aspires to be the trusted health partner for all Indians and its mission is to make healthcare accessible, understandable and affordable for a billion Indians. It enables consumers to learn more about their medicines and also find more cost-effective substitutes. 1mg’s doctor platform aims to revolutionize how a consumer finds the right healthcare professional for his needs. It’s diagnostics service brings transparency and price-effectiveness to lab tests. 1mg is an initiative taken in the spirit of public service with a vision to empower Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price. The application is available as a web portal– www.1mg.com and as mobile app across Android/ iOS.

Netmeds.com is a fully licensed e-pharma portal that offers authenticated prescription and Over the Counter (OTC) medicine along with other health products. Netmeds is the “first-to-market” to offer a pan-India solution for the quick online purchase and fast delivery of prescription medications and has served more than 5.7 million customers in more than 670 cities and towns. The portal offers customers the convenience of ordering health products online via a simple process. A team of qualified pharmacists’ vets the prescription for validity and dosage that assures dispensing only appropriate medication. Through Netmeds, consumers get access to more than 70,000 prescription drugs for chronic and recurring ailments as well as enhanced lifestyle drugs and thousands of non-prescription goods for wellness, health, and personal care. Netmeds.com is promoted by Dadha Pharma, a Chennai-based company and backed by investors including MAPE Advisory, OrbiMed, Tanncam, Sistema and Daun Penh. The Dadha family’s pharmaceutical experience dates back to 1914, when they ventured first into the pharma retailing business and then into drug manufacturing in 1972.

Launched in 2015, PharmEasy is pharmacy made easy! Started with the sole purpose of making healthcare accessible and affordable to all, PharmEasy today is India’s leading and most trusted online healthcare aggregator in the country. We help patients connect with local pharmacy stores and diagnostic centers to fulfill their extensive medical needs. We believe that everyone should have access to good health. Thus, through our services, we ensure you get access to the best and most genuine health products, with the highest savings in the shortest time possible. Today, we deliver medicines in 1000+ cities in India, covering 22000+ pin codes. We offer diagnostic test services across Mumbai including Thane, Navi Mumbai, Kalyan & Dombivali, Delhi with Noida, Gurgaon, Faridabad & Ghaziabad, Chennai, Pune, Ahmedabad, and Gandhi Nagar, Surat, Vadodara, Lucknow, Kolkata, Hyderabad, Bengaluru, and Jaipur. In addition to making healthcare accessible to all, through our technological innovations, we aim to revolutionize the healthcare system by: A) Making the industry data driven by providing doctors and patients the most accurate information to make decisions B) Making healthcare a universal right by making it quantum's cheaper and accessible C) Constructing a feedback loop for pharma companies enabling them to make better drugs to combat diseases like never before D) Eradicating fake medicines which contribute 30% of drug volume in India E) Reducing drug dependency and drug abuse And, to do so, we are looking for like-minded and talented folks to join our growing family! https://pharmeasy.in/careers/

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities.

Brightech International, a CRO focused on clinical data solutions, provides high quality Biostatistics, SAS Programming, Data Management, Medical Writing, and Regulatory Strategy services since 2002. We bring expertise, experience and excellent track records to support 25+ long-term clients. We also provide specialty CDISC services and manage a sophisticated proprietary eClinical Suite (CIMS). Clinical Data Solutions Brightech is recognized as an innovator shaped by our industry-leading approach, clinical data methodology and client centric focus. We provide comprehensive end-to-end data services in clinical data management, biostatistics / SAS programming, clinical data standardization, regulatory submissions, and medical writing resulting in successful clinical trial activities. Clinical Data Intelligence Our trial design strategies streamline your clinical trial process to achieve your specific study objectives. Our biostatistical experts are capable of implementing the most complex analytic solutions. Our experienced data managers deploy optimized strategies and procedures to manage your clinical data in any system. In addition, we provide specialty CDISC services and manage a sophisticated proprietary integrated Clinical Information Management Suite (CIMS). Industry Leadership With our thought leadership and industry-leading solutions, we are a global CRO focused on clinical data solutions, providing high quality services since 2002. Our proven expertise, superior experience and excellent track record have supported over 25 long-term clients resulting in multiple successful NDA approvals.

As India's leading integrated healthcare company, Practo has been on a mission to make quality healthcare accessible and affordable to all by connecting the entire healthcare ecosystem including patients, doctors, clinics, hospitals, pharmacies, and diagnostics in a seamless and cohesive manner. Practo effortlessly streamlines the patient's healthcare journey right from primary healthcare, viz. finding and booking an appointment with verified doctors, consulting doctors online with ETA as low as 60 seconds, getting medicines delivered and lab tests conducted at home, providing health plans to corporates, to secondary healthcare procedures. Practo also makes software products that help healthcare providers - ranging from small clinics to large hospitals - digitize and deliver more efficient and higher quality healthcare to millions of patients around the world. Practo is also one of the few healthcare companies to employ 256-bit encryption, HIPAA-compliant data centers, and hold ISO 27001 certification—ensuring data security at all times. Currently, Practo has helped over 30Cr+ patients with the help of 1.2L+ verified doctor-partners in 22+ countries.

The Julphar story is one of innovation and leadership. Since our journey began in 1980, our goal has remained the same – to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, we have expanded our network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region. Headquartered in Ras Al Khaimah in the United Arab Emirates, we employ 2,500 people worldwide, and we market our products in more than 50 countries. We have 13 internationally accredited facilities that produce more than half a million medicine boxes a day, including tablets, syrups, suspensions, creams and injectables, and vaccines. Julphar has an extensive portfolio of generic medicines, branded generics, and over-the-counter medicines, as well as APIs (active pharmaceutical ingredients). We develop and manufacture medicines and supplements for everything from the common cold to diabetes.

Thank you to everyone who has contributed to our journey and supported us along the way... Welcome to our new brand and the pharmacy of the future, Phlo. The Organised Health brand is being retired but do check us out at Phlo to keep up to date with us. www.wearephlo.com

Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company’s vendor-agnostic Honey Platform™ is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment – providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step pre-qualification, and meaningful Omnichannel partners focused on patient advocacy, community engagement, and diversity. To take control of patient recruitment for your next study, visit http://www.trialbee.com/.

Ionetix is a cyclotron and technology company providing full-service radioisotope production and end-to-end radiopharmaceutical manufacturing solutions by actively establishing a network of ION-12SCs installed on or near the campus of PET programs across the country. By covering all costs related to the installation and ongoing operation of the cyclotron and making N-13 Ammonia available to providers through a pay-by-the-dose model, we are making this critical tracer accessible and affordable to providers nationwide. Our more recent endeavors involve leveraging our growing network of radiopharmaceutical manufacturing locations to support the development and commercialization of targeted alpha therapy (TAT), an emerging cancer therapy utilizing alpha radionuclides. The time is now to harness the power to deliver cutting edge diagnostics and therapeutics. We encourage you to visit our website for more information or message our LinkedIn page with any questions.

Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company has conducted digital data collection for over 300 clinical trials in 90 countries (100,000 patients), employing 120 languages. It has offices in the US (Boston), France (Grenoble) and Japan (Tokyo), and currently employs 185 staff.

Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.

Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence.  Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, Pain Treatment & CNS, and Late Phase & RWE.

The Bioseutica Group - Overview Bioseutica is a vertically integrated specialty pharmaceutical group with a global presence dedicated to the development of the highest quality products, using natural, renewable sources for the healthcare, diagnostic media, food and feed industries. We are at the forefront of reliable scientific research leading to innovative products and proprietary technologies. Bioseutica focuses on the global supply of the highest quality Natural Proteins, including Pancreatic Enzymes, as well as on the licensing of related intellectual property. Bioseutica’s specialized and proprietary manufacturing expertise is able to produce ingredients to high purities from its manufacturing facilities in the Americas and Europe. Today, Bioseutica’s Natural Protein Division (North America, Europe) is the global leader and producer of Lysozyme, which the company has been extracting from hen egg white (HEW) for a broad spectrum of applications since 1947.

Actando is an innovative global learning organisation that empowers life sciences customers with skills and tools that drive business performance and accelerate overall organisational effectiveness. We’ve seen a lot of change occur in life sciences—and recognize that quickly adapting to change is not easy. Success in this industry requires specific knowledge and skills and we work hard to acquire and offer this expertise to our clients. Our team is made up of a focused group of experts that touch each aspect of life sciences—including sales, marketing and commercial excellence, along with the technological know-how to make it work. We know this world and its unique aspects and can help you adapt and succeed quickly. Our team is committed to creating environments of continuous learning, and we work hard to arm you with all the relevant data, insights, and recommendations to help your organization keep climbing. Our unique blended learning programmes, supported by ongoing assessment, implementation and decision-making data and tools, empower sales, marketing and commercial life sciences teams to effectively plan, execute and measure performance. The results are employees who can thrive in the midst of market change and companies who can stop playing catch up and start operating successfully in today’s fast-paced world.

Dulac Farmaceutici 1982 is a research and innovation oriented factory. Thanks to our high standards, we developed many different brands within the pharmaceutical market of medical devices, parapharmacy, medical products, dietary supplements and make up. By investing in research and development, together with many partners and high level laboratories, we also generated modern and efficient communication strategies to always act through the best national distributive networks in order to offer the sales points and the customer a continual and professional attendance. In 2014, Dulac Farmaceutici 1982 obtained the Guarantee System of Production Quality for the medical devices by the National Institute of Health. Our History Dulac Farmaceutici 1982 has dealt with development and marketing of innovative products for three generations. We guarantee the best reliability and competence by taking advantage of the best chemical laboratories and more than forty years of experience in this sector. Our factory avails of a well prepared and young team marketing that confers to our products an efficient positioning, a typical leader-factory attention to details, together with client-oriented dynamism and flexibility, in order to provide the best possible service. Italian Quality In order to constantly ensure the supply of effective, safe and innovative products, Dulac Farmaceutici 1982 has developed a detailed Integrated Quality management system. Our procedures, operative instructions and set of forms take account of all the Quality insurance, Production, Quality Control, Logistics, Commercial ad Purchase areas. The application and effectiveness of our system are periodically monitored with internal audit, meeting with the suppliers and close relations with the distribution network, in order to control and improve the products, in all of their particulars. All our products fulfil the best European quality standards and are 100% made in Italy.

Spoedtest.nl faciliteert sinds september 2020 toegankelijke, betrouwbare en snelle coronatesten, door gecertificeerde medewerkers volgens de standaarden van het RIVM en de Inspectie van Gezondheidszorg en Jeugd. Dit gebeurt vanuit een van de 120+ vestigingen van Spoedtest.nl. De uitslag van een antigeentest (sneltest) krijgt men binnen 30 minuten, de uitslag van een PCR-test al na enkele uren, inclusief een wereldwijd erkend reiscertificaat. Met partners zoals de Nederlandse overheid, TUI, Koninklijke Horeca Nederland, de NH Hotel Groep en verscheidene Arbodiensten is Spoedtest.nl marktleider op het gebied van coronatesten in Nederland. Vanaf mei 2022 is het aanbod van testen uitgebreid met soa thuistesten.

Our mission is to develop innovative technology and software to improve medicines management, now and in the future. TITAN is an innovative new PMR with complete flexibility over pharmacy processes to improve business effectiveness.

Your trusted health expert, PetMeds® is a publicly traded company (NASDAQ: PETS). We deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. We serve millions of satisfied customers nationwide from one location.

Vetark has changed the landscape of exotic animal nutrition in the UK with its unique vitamin and supplement ranges, addressing the industry‘s need for product efficacy and integrity. All of our products are scientifically based, with the formulations having been developed by RCVS recognised veterinary specialists, and we are proud to be certified to manufacture veterinary medicines under the Exemption for Small Pet Animals (ESPA). Recommended and supplied by vets, Vetark products are now available in over 20 countries worldwide. The product ranges are also used by universities, scientists, and zoos, as well as pet owners.

Since 1992, Life Scientific, Inc., based in St. Louis, MO, has helped facilitate hundreds of Pharmaceutical Process and Packaging Equipment projects. Over the years we have developed significant experience in finding the best solutions for both our clients and the manufacturers we represent. Our website provides a brief overview of the manufacturers we represent and links to their respective websites along with the products page on here. Our company works with reputable, reliable, high quality equipment from the best manufacturers in the U.S. and abroad.Our product line includes: Aseptic Enclosures, Bioreactors and Fermenters, Heat transfer and temperature control systems; Isolators, hoods and cleanrooms; Precision cooling, filling, washing and closing systems; Stability testing chambers, freezer; Packaging equipment; Labeling machines; and Lyophilization related goods and services. Technical services include, control system upgrades, validation, calibration, preventative maintenance and refrigeration repair.

With over 25 years experience consolidating our position as the leading independent service provider for HPLC, GC, LCMS, GCMS, ICP and ICPMS. LC Services is an independent service organisation formed in 1989 and boasting a full compliment of highly qualified engineers, providing expert care, maintenance and troubleshooting of chromatography systems, with exclusive global OEM Partnerships. Strategically located in the beautiful village of Turvey in Bedfordshire, from where there are excellent transport links to all of the UK nationwide and European clients. LC Services Ltd have some of the most impressive facilities, fully equipment workshops and laboratories in the industry. ◦BS EN ISO 9001 : 2015 ◦ Comprehensive and highly technical staff to serve all our customers efficiently ◦ Geographically based field engineers including our service manager providing immediate attention to our customers ◦ In-house engineers providing services for our exchange/refurbish programme ◦ Account managers on call to discuss your requirements ◦ Optics engineers providing all your lamp and optics needs ◦ In-house staff providing comprehensive backup support, available online, on the phone or in person ◦ Large onsite stock of consumables for global rapid dispatch ◦ 3 x on-site laboratories *NEW ICP Lab (2016)* ◦ Workshop and testing area ◦ Manufacturing/development building ◦ Instrument room ◦ Refurbished exchange modules - some no longer supported by the OEM Focusing on service, support and all your consumable needs for your chromatography equipment allows us to pay attention to all aspects of our customers requirements. We offer various support packages for the requirements of our individual clients: • Various manufacturers supported • Maintenance packages • Training packages • Operational qualification

ValiTech is a global leading consultancy company. We formed while we had identified the need for specialists to integrate equipment and critical systems into the pharma industry. Our team has a vast knowledge in the pharmaceutical, biotech, Medical and life-science industries. We specialize in a board range of equipment and critical systems commissioning & qualification. We support our clients with -Validation -Engineering/Design & Development for (Medical & IoT Devices) -Project Management -Regulatory Affairs Our team with a demonstrated hands-on industry experience can provide on-site consulting services to ensure that all processes, equipment and systems consistently meet their predefined acceptance criteria adhering to current regulatory requirements. ValiTech -We Distribute Quality-

Shree Ganesh Remedies Ltd. is established Since 1995 with an aim to manufacture, supply and export best quality of Pharmaceutical-intermediates, Bulk drugs, and Speciality Chemicals to cater to the needs of pharmaceutical companies and drug companies for research and product development purposes. We are also one of the preferred partners for CRAMS and CMO for many reputed pharmaceutical and specialty chemical companies all over the globe. To know more, please drop us an email at contact@ganeshremedies.com and fill out the form on our website.

Trade Maantra is a fastest-emerging B2B pharmaceutical marketplace in India for manufacturers, suppliers, exporters, traders, & buyers. Trade Maantra is dealing in the pharmaceutical industry, Ayurvedic & Herbal industry, Hospital & medical equipment industry, Agricultural industry, & many more Indian industries. Get a list of top WHO GMP ISO Certified Pcd Pharma Franchise Companies & Third Party Pharmaceutical Manufacturing Companies in PAN India only with Trade Maantra.

Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. The company benefits from a close working relationship with the School of Life Sciences at the University of Sussex.

As a pharmacy or dispensing practice owner – your world is getting tougher. So making your purchasing profitable is as critical as it’s ever been. But finding & buying drugs for your patients is opaque, complex and prices are more volatile than ever. For 20 years, Cambrian Alliance has existed to make independents stronger and adapt to the constant change in Pharmacy. With our buying platform e-CASS, you can quickly check prices for products across suppliers, control your over-tariff losses and fine-tune how your team buy every day so you can balance getting prescriptions fulfilled with profit. e-CASS makes it easy to compare, control & make profit on your drug purchasing and as the largest independent buying group, we use our collective strength to negotiate the best prices on more than 25,000 lines for you. Our team of Business and Account Service Managers ensure you and your team are getting the best out of e-CASS’ innovations and profits from your products. Because we are run by pharmacists and dispensers, for you, we are constantly adding to our roadmap of investments.

Biopharma Institute offers a world-class training experience for students and training managers. Our mission is to provide the compliance training necessary to assist both professionals and their corporate employers with maintaining a safe environment for employees and consumers, while aiming to achieve a competitive edge in the marketplace by producing a dependable product or service. Biopharma Institute delivers this by centering its attention on supplying remote training that is reliable, easy to access, current on regulations, and effective at transferring knowledge.

PLD is a leading supplier of over-the-counter solid and liquid dose remedies in the Analgesic, Cough/Cold, Allergy, Sleep/Awake/Motion, Digestive, Nutritional, First Aid, Electrolyte and Epsom Salt categories. We pride ourselves on delivering the highest quality product in the most cost-efficient manner possible. This includes adhering to cGMP and stringent FDA regulations, so every product we manufacture meets and even exceeds the industry's rigorous standards. Since we began in 1988, it is our unwavering commitment to excellence that has enabled us to grow to serve every major retailer in the U.S. and many around the globe. Today we remain at the forefront of the consumer healthcare industry with 1,000+ dedicated employees and more than 1,000,000 sq. ft. of state-of-the-art facilities across New York, California, Florida and South Carolina. Our Mission To provide high quality and affordable healthcare products that help people feel well through services that cultivate trust and confidence. We foster an environment where people are passionate about their work and the wellbeing of their communities. Our Vision To be the most respected, efficient, and reliable partner delivering healthcare products and services that improve People's Lives Daily. Interested in a career at PLD? Please visit: http://www.pldevelopments.com/careers/

Pharma IQ, is the international online community focusing on providing pharmaceutical professionals with knowledge, information and insight. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community

The Reg Consultants Pte Ltd (TRC) is a fast growing regulatory company based in ASEAN's regional hub: Singapore. It was founded in 2017 to provide support to overseas companies who wishes to expand their territory in the ASEAN market but did not have the right regulatory expertise as well as local market knowledge and resources to do so. Therefore, TRC would like to function as their internal representative office to assist the Clients to deal with their regulatory portfolio while they can focus their efforts in the commercial operations. A successful product launch depends on having a short lead time in obtaining product approval coupled with the right marketing strategy. Therefore, our motto of the business is "Bridging Regulatory and Commercial into One"​.